CHR
Cheer Holding, Inc.
There isn't enough reported data to score CHR yet.
TMUS
T-Mobile US, Inc.
TMUS's fundamentals are mixed, but it looks cheap: trading at 16x earnings, below its usual 27x. Analysts expect strong earnings growth.
CHR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
CHR's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CHR PE Valuation
CHR has no meaningful PE right now: it lost money over the past year.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
CHR Forward outlook
There aren't enough analyst estimates for CHR to show an outlook.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TMUS, with profitability improving.
CHR Earnings Per Share
CHR and TMUS do not have enough comparable growth data to identify a winner.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS earned $10.37 per share over the past year, about the same as the year before.
CHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $30.3M | -15% |
| Q1 2026 | $30.3M | -15% |
| Q4 2025 | $38.9M | +2.2% |
| Q3 2025 | $38.9M | +2.2% |
| Q2 2025 | $35.5M | -50% |
| Q4 2024 | $38.1M | -55% |
| Q2 2024 | $71.1M | +5.4% |
| Q4 2023 | $84.9M | -2.6% |
CHR's revenue has slid since its 2022 peak: $30M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.6 points |
| Q1 2026 | 17% | +5.6 points |
| Q4 2025 | 23% | +4.8 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 12% | -4.6 points |
| Q1 2025 | 12% | N/A |
| Q4 2024 | 18% | -5.9 points |
| Q3 2024 | 18% | N/A |
CHR's operating margin was 17% last quarter, up 5.6 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over CHR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over CHR on profitability, with a higher operating margin.
CHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.1M | -871% |
| Q1 2026 | $17.9M | +815% |
| Q4 2025 | $7M | -53% |
| Q3 2025 | $7M | -53% |
| Q2 2025 | $2M | +$8.7M |
| Q1 2025 | $2M | +$5.3M |
| Q4 2024 | $14.8M | -1.3% |
| Q3 2024 | $14.8M | +97% |
CHR usually generates cash, though not every quarter: the latest was −$15M, but it generated $17M over the past year.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over CHR on cash flow, with more consistent year-over-year improvement.
CHR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -62% | -124K shares |
| 3 years | +1564% | +72.6K shares |
CHR has the edge over TMUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has 1.1B diluted shares, down 4.9% from a year ago, with $12B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
CHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.8x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -6.7x | Net Cash |
| Q3 2025 | -7.6x | Net Cash |
| Q2 2025 | -7.5x | Net Cash |
| Q1 2025 | -5.7x | Net Cash |
CHR has the edge over TMUS on leverage, with a lower net debt burden relative to earnings.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
CHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.6 | Oversold |
| Stochastic | 15.4 | Oversold |
CHR's weekly RSI is 26 (oversold) and its Stochastic is 15 (oversold).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
CHR PE vs Communication Services Sector
CHR has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
CHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.43 | 7.7% below |
| 20 week MA | $1.67 | 21% below |
| 50 week MA | $2.59 | 49% below |
| 100 week MA | $103.9 | 99% below |
| 200 week MA | $363.1 | 100% below |
CHR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over CHR on trend strength, trading above more of its moving averages.
CHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15,450.0 | $3,945.0 | -74% |
| 2021 | $3,945.0 | $1,935.0 | -51% |
| 2022 | $1,935.0 | $2,220.0 | +15% |
| 2023 | $2,220.0 | $471.0 | -79% |
| 2024 | $471.0 | $387.0 | -18% |
| 2025 | $387.0 | $4.38 | -99% |
| 2026 YTD | $4.38 | $1.32 | -70% |
CHR has finished three years in a row lower, and it's down 70% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over CHR on returns for 2026, with the stronger performance.